Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
NCT: NCT05874479 · RECRUITING
Brief Summary
Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.
Frequently Asked Questions
What is Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents?
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents is a clinical trial registered under NCT05874479. Current status: RECRUITING.
What is the status of NCT05874479?
The current status of NCT05874479 (Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents) is: RECRUITING.
When did Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents start?
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents started on 2023-12-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.